Gentian Diagnostics AS (OL:GENT) — Stock Price
Gentian Diagnostics AS (OL:GENT) is currently trading at Nkr40.50 NOK, down 0.49% today. Over the past 52 weeks, shares have ranged between Nkr34.60 and Nkr59.00. This page tracks Gentian Diagnostics AS's live share price on the OL exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Gentian Diagnostics AS.
Gentian Diagnostics AS (GENT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Gentian Diagnostics AS's daily closing share price and trading volume on the OL exchange over the past year, giving a clear view of recent price momentum and liquidity.
Gentian Diagnostics AS Income Statement — Revenue, Profit & Earnings by Year
Gentian Diagnostics AS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Nkr176.50 Million | Nkr152.07 Million | Nkr136.19 Million | Nkr101.64 Million | Nkr83.12 Million |
| Cost of Revenue | Nkr78.30 Million | Nkr69.25 Million | Nkr70.91 Million | Nkr52.63 Million | Nkr43.18 Million |
| Gross Profit | Nkr98.20 Million | Nkr82.82 Million | Nkr65.29 Million | Nkr49.00 Million | Nkr39.95 Million |
| Research & Development | Nkr23.16 Million | Nkr21.92 Million | Nkr36.08 Million | Nkr24.69 Million | Nkr26.81 Million |
| SG&A | Nkr54.33 Million | Nkr21.71 Million | Nkr25.05 Million | Nkr46.59 Million | Nkr38.41 Million |
| Total Operating Expenses | Nkr151.05 Million | Nkr67.09 Million | Nkr77.01 Million | Nkr72.24 Million | Nkr62.79 Million |
| Operating Income | Nkr25.45 Million | Nkr15.72 Million | Nkr-12.76 Million | Nkr-23.23 Million | Nkr-22.85 Million |
| EBITDA | — | Nkr31.54 Million | Nkr-3.08 Million | Nkr-15.94 Million | Nkr-18.38 Million |
| EBIT | — | Nkr22.58 Million | Nkr-9.57 Million | Nkr-22.30 Million | Nkr-23.34 Million |
| Interest Expense | Nkr5.22 Million | Nkr2.52 Million | Nkr871.00K | Nkr1.32 Million | Nkr1.45 Million |
| Income Before Tax | Nkr25.67 Million | Nkr20.06 Million | Nkr-10.37 Million | Nkr-23.62 Million | Nkr-24.79 Million |
| Income Tax Expense | — | Nkr-25.23 Million | Nkr282.00K | Nkr383.00K | — |
| Net Income | Nkr13.26 Million | Nkr45.29 Million | Nkr-10.65 Million | Nkr-24.00 Million | Nkr-24.79 Million |
Gentian Diagnostics AS Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Gentian Diagnostics AS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Nkr258.54 Million | Nkr229.66 Million | Nkr181.04 Million | Nkr187.79 Million | Nkr211.79 Million |
| Total Current Assets | Nkr184.34 Million | Nkr161.96 Million | Nkr141.73 Million | Nkr139.33 Million | Nkr167.29 Million |
| Cash & Equivalents | — | Nkr84.74 Million | Nkr2.01 Million | Nkr2.08 Million | Nkr114.94 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Nkr24.27 Million | Nkr31.27 Million | Nkr16.98 Million | Nkr19.19 Million | Nkr22.58 Million |
| Inventory | Nkr54.14 Million | Nkr45.94 Million | Nkr37.12 Million | Nkr38.54 Million | Nkr29.78 Million |
| Property, Plant & Equipment | — | Nkr14.02 Million | Nkr18.05 Million | Nkr21.64 Million | Nkr19.49 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Nkr53.58 Million | Nkr35.61 Million | Nkr34.40 Million | Nkr33.62 Million | Nkr37.02 Million |
| Total Current Liabilities | Nkr34.14 Million | Nkr30.11 Million | Nkr25.32 Million | Nkr22.00 Million | Nkr22.55 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | Nkr-74.70 Million | Nkr-74.59 Million | Nkr-66.28 Million | Nkr-96.35 Million |
| Total Stockholder Equity | Nkr204.96 Million | Nkr194.05 Million | Nkr146.64 Million | Nkr154.17 Million | Nkr174.77 Million |
| Retained Earnings | Nkr-114.62 Million | Nkr-121.32 Million | Nkr-167.05 Million | Nkr-156.48 Million | Nkr-132.53 Million |
Gentian Diagnostics AS Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Gentian Diagnostics AS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Nkr42.59 Million | Nkr13.46 Million | Nkr15.46 Million | Nkr-13.95 Million | Nkr-27.05 Million |
| Capital Expenditures | Nkr10.76 Million | Nkr10.95 Million | Nkr4.49 Million | Nkr14.67 Million | Nkr12.81 Million |
| Free Cash Flow | Nkr31.83 Million | Nkr2.51 Million | Nkr10.97 Million | Nkr-28.62 Million | Nkr-39.87 Million |
| Investing Cash Flow | Nkr-10.76 Million | Nkr-10.95 Million | Nkr-4.88 Million | Nkr-14.67 Million | Nkr-12.81 Million |
| Financing Cash Flow | Nkr-11.13 Million | Nkr-4.95 Million | Nkr-4.60 Million | Nkr-4.33 Million | Nkr-3.12 Million |
| Dividends Paid | Nkr6.17 Million | — | — | — | — |
| Stock-Based Compensation | Nkr3.31 Million | Nkr2.58 Million | Nkr3.04 Million | Nkr3.35 Million | Nkr4.63 Million |
| Depreciation | Nkr9.12 Million | Nkr8.96 Million | Nkr9.57 Million | Nkr10.24 Million | Nkr7.35 Million |
| Change in Cash | Nkr21.19 Million | Nkr-2.90 Million | Nkr6.04 Million | Nkr-33.34 Million | Nkr-43.05 Million |
Gentian Diagnostics AS Earnings History — EPS Actual vs. Analyst Estimates
Track Gentian Diagnostics AS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 12, 2026 | 0.22 | — | — |
| Oct 24, 2025 | 0.26 | — | — |
| Jul 11, 2025 | -0.13 | — | — |
| May 07, 2025 | 0.49 | — | — |
| Feb 12, 2025 | 2.09 | — | — |
| Oct 31, 2024 | 0.21 | — | — |
| Aug 29, 2024 | 0.30 | — | — |
| Apr 30, 2024 | 0.27 | — | — |